Alma Bio Therapeutics
Records under this name other than patents Alma Bio Therapeutics holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned.
Showing 1 to 6 of 6 · Back to Alma Bio Therapeutics
Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 11,992,533 | Methods of Treatment of HLA-B27 Related Inflammatory Diseases and Compositions Related to Same Formerly held In force · High confidence | In force | High confidence | |
| US 9,974,843 | DNA vaccines encoding heat shock proteins Term ended Term ended Jun 11, 2023 · USPTO record | Term ended | Term ended Jun 11, 2023 | USPTO record |
| US 8,058,254 | DNA vaccines encoding heat shock proteins Term ended Term ended May 21, 2023 · USPTO record | Term ended | Term ended May 21, 2023 | USPTO record |
| US 8,361,987 | DNA Vaccines Encoding Heat Shock Proteins Term ended Term ended May 21, 2023 · Medium confidence | Term ended | Term ended May 21, 2023 | Medium confidence |
| US 9,283,265 | DNA vaccines encoding heat shock proteins Term ended Term ended May 21, 2023 · USPTO record | Term ended | Term ended May 21, 2023 | USPTO record |
| US 10,226,517 | DNA Vaccines Encoding Heat Shock Proteins Term ended Ended no later than May 21, 2023 · Low confidence | Term ended | Ended no later than May 21, 2023 | Low confidence |